Polycystic ovary syndrome: associations with cardiovascular disease

References

• Bozdag G, Mumusoglu S, Zengin D, et al. The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod. 2016;31(12):2841–2855. doi: 10.1093/humrep/dew218.
   PubMed Web of Science ®Google Scholar
• Rotterdam EA-SPCWG. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi: 10.1016/j.fertnstert.2003.10.004.
   Web of Science ®Google Scholar
• Joham AE, Norman RJ, Stener-Victorin E, et al. Polycystic ovary syndrome. Lancet Diabetes Endocrinol. 2022;10(9):668–680. doi: 10.1016/S2213-8587(22)00163-2.
   PubMed Web of Science ®Google Scholar
• Lim SS, Kakoly NS, Tan JWJ, et al. Metabolic syndrome in polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Obes Rev. 2019;20(2):339–352. Feb 2019;20(2):339–352. doi: 10.1111/obr.12762.
   PubMed Web of Science ®Google Scholar
• Persson S, Elenis E, Turkmen S, et al. Higher risk of type 2 diabetes in women with hyperandrogenic polycystic ovary syndrome. Fertil Steril. 2021;116(3):862–871. doi: 10.1016/j.fertnstert.2021.04.018.
   PubMed Web of Science ®Google Scholar
• Rubin KH, Glintborg D, Nybo M, et al. Development and risk factors of type 2 diabetes in a nationwide population of women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2017;102(10):3848–3857. doi: 10.1210/jc.2017-01354.
   PubMed Web of Science ®Google Scholar
• Mousa AT, Chau T, Teede H. Technical report for the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. 2023. doi: 10.26180/23625288.v1.
   Google Scholar
• Teede HJ, Tay CT, Laven JJE, et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome*. J Clin Endocrinol Metabol. 2023;108(10):2447–2469. doi: 10.1210/clinem/dgad463.
   PubMedGoogle Scholar
• Dumesic DA, Oberfield SE, Stener-Victorin E, et al. Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome. Endocr Rev. 2015;36(5):487–525. doi: 10.1210/er.2015-1018.
   PubMed Web of Science ®Google Scholar
• Snyder ML, Shields KJ, Korytkowski MT, et al. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls. Gynecol Endocrinol. 2014;30(7):511–515. doi: 10.3109/09513590.2014.895985.
   PubMed Web of Science ®Google Scholar
• Alexandraki KI, Kandaraki EA, Poulia KA, et al. Assessment of early markers of cardiovascular risk in polycystic ovary syndrome. touchREV Endocrinol. 2021;17(1):37–53. doi: 10.17925/EE.2021.17.1.37.
   PubMedGoogle Scholar
• Atiomo WU, Bates SA, Condon JE, et al. The plasminogen activator system in women with polycystic ovary syndrome. Fertil Steril. 1998;69(2):236–241. doi: 10.1016/s0015-0282(97)00486-x.
   PubMed Web of Science ®Google Scholar
• Talbott EO, Zborowski JV, Rager JR, et al. Evidence for an association between metabolic cardiovascular syndrome and coronary and aortic calcification among women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2004;89(11):5454–5461. doi: 10.1210/jc.2003-032237.
   PubMed Web of Science ®Google Scholar
• Talbott EO, Guzick DS, Sutton-Tyrrell K, et al. Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol. 2000;20(11):2414–2421. doi: 10.1161/01.atv.20.11.2414.
   PubMed Web of Science ®Google Scholar
• de Groot PC, Dekkers OM, Romijn JA, et al. PCOS, coronary heart disease, stroke and the influence of obesity: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(4):495–500. doi: 10.1093/humupd/dmr001.
   PubMed Web of Science ®Google Scholar
• Calderon-Margalit R, Siscovick D, Merkin SS, et al. Prospective association of polycystic ovary syndrome with coronary artery calcification and carotid-intima-media thickness: the Coronary Artery Risk Development in Young Adults Women’s study. Arterioscler Thromb Vasc Biol. 2014;34(12):2688–2694. doi: 10.1161/ATVBAHA.114.304136.
   PubMed Web of Science ®Google Scholar
• Zhang J, Xu JH, Qu QQ, et al. Risk of cardiovascular and cerebrovascular events in polycystic ovarian syndrome women: a meta-analysis of cohort studies. Front Cardiovasc Med. 2020;7:552421. doi: 10.3389/fcvm.2020.552421.
   PubMed Web of Science ®Google Scholar
• Wekker V, van Dammen L, Koning A, et al. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis. Hum Reprod Update. 2020;26(6):942–960. doi: 10.1093/humupd/dmaa029.
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Amiri M, Behboudi-Gandevani S, et al. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis. Gynecol Endocrinol. 2020;36(1):12–23. doi: 10.1080/09513590.2019.1650337.
   PubMed Web of Science ®Google Scholar
• Tay CT, Garrad R, Mousa A, et al. Polycystic ovary syndrome (PCOS): international collaboration to translate evidence and guide future research. J Endocrinol. 2023;257(3):e220232. doi: 10.1530/JOE-22-0232.
   PubMed Web of Science ®Google Scholar
• Millán-de-Meer M, Luque-Ramírez M, Nattero-Chávez L, et al. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis. Hum Reprod Update. 2023;29(6):741–772. doi: 10.1093/humupd/dmad015.
   PubMed Web of Science ®Google Scholar
• Jacewicz-Święcka M, Wołczyński S, Kowalska I. The effect of ageing on clinical, hormonal and sonographic features associated with PCOS-a long-term follow-up study. J Clin Med. 2021;10(10):2101. doi: 10.3390/jcm10102101.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Brannstrom M, Landin-Wilhelmsen K, et al. Reproductive hormone levels and anthropometry in postmenopausal women with polycystic ovary syndrome (PCOS): a 21-year follow-up study of women diagnosed with PCOS around 50 years ago and their age-matched controls. J Clin Endocrinol Metab. 2011;96(7):2178–2185. doi: 10.1210/jc.2010-2959.
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Montazeri SA, Hosseinpanah F, et al. Trend of cardio-metabolic risk factors in polycystic ovary syndrome: a population-based prospective cohort study. PLoS One. 2015;10(9):e0137609. doi: 10.1371/journal.pone.0137609.
   PubMed Web of Science ®Google Scholar
• Behboudi-Gandevani S, Ramezani Tehrani F, Hosseinpanah F, et al. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study. Fertil Steril. 2018;110(7):1377–1386. doi: 10.1016/j.fertnstert.2018.08.046.
   PubMed Web of Science ®Google Scholar
• Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, et al. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril. 2017;108(6):1078–1084.
   PubMed Web of Science ®Google Scholar
• Welt CK, Carmina E. Lifecycle of polycystic ovary syndrome (PCOS): from in utero to menopause. J Clin Endocrinol Metab. 2013;98(12):4629–4638. doi: 10.1210/jc.2013-2375.
   PubMed Web of Science ®Google Scholar
• Apridonidze T, Essah PA, Iuorno MJ, et al. Prevalence and characteristics of the metabolic syndrome in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90(4):1929–1935. Apr doi: 10.1210/jc.2004-1045.
   PubMed Web of Science ®Google Scholar
• Amiri M, Ramezani Tehrani F, Behboudi-Gandevani S, et al. Risk of hypertension in women with polycystic ovary syndrome: a systematic review, meta-analysis and meta-regression. Reprod Biol Endocrinol. 2020;18(1):23. doi: 10.1186/s12958-020-00576-1.
   PubMed Web of Science ®Google Scholar
• Gilbert EW, Tay CT, Hiam DS, et al. Comorbidities and complications of polycystic ovary syndrome: an overview of systematic reviews. Clin Endocrinol (Oxf). 2018;89(6):683–699. doi: 10.1111/cen.13828.
   PubMed Web of Science ®Google Scholar
• Baranova A, Tran TP, Birerdinc A, et al. Systematic review: association of polycystic ovary syndrome with metabolic syndrome and non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2011;33(7):801–814. doi: 10.1111/j.1365-2036.2011.04579.x.
   PubMed Web of Science ®Google Scholar
• Meun C, Gunning MN, Louwers YV, et al. The cardiovascular risk profile of Middle-aged women with polycystic ovary syndrome. Clin Endocrinol (Oxf). 2020;92(2):150–158. doi: 10.1111/cen.14117.
   PubMed Web of Science ®Google Scholar
• Sutton-Tyrrell K, Wildman RP, Matthews KA, et al. Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women across the Nation (SWAN). Circulation. 2005;111(10):1242–1249. doi: 10.1161/01.CIR.0000157697.54255.CE.
   PubMed Web of Science ®Google Scholar
• Zhuang C, Luo X, Wang W, et al. Cardiovascular risk according to body mass index in women of reproductive age with polycystic ovary syndrome: a systematic review and meta-analysis. Systematic review. Front Cardiovasc Med. 2022;9:822079. doi: 10.3389/fcvm.2022.822079.
   PubMed Web of Science ®Google Scholar
• Oliver-Williams C, Vassard D, Pinborg A, et al. Risk of cardiovascular disease for women with polycystic ovary syndrome: results from a national Danish registry cohort study. Eur J Prev Cardiol. 2021;28(12):e39–e41. doi: 10.1177/2047487320939674.
   PubMed Web of Science ®Google Scholar
• Brown ZA, Louwers YV, Fong SL, et al. The phenotype of polycystic ovary syndrome ameliorates with aging. Fertil Steril. 2011;96(5):1259–1265. doi: 10.1016/j.fertnstert.2011.09.002.
   PubMed Web of Science ®Google Scholar
• Lim SS, Norman RJ, Davies MJ, et al. The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis. Obes Rev. 2013;14(2):95–109. Feb 2013;14(2):95–109. doi: 10.1111/j.1467-789X.2012.01053.x.
   PubMed Web of Science ®Google Scholar
• Lim SS, Davies MJ, Norman RJ, et al. Overweight, obesity and Central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(6):618–637. doi: 10.1093/humupd/dms030.
   PubMed Web of Science ®Google Scholar
• Dobbie LJ, Pittam B, Zhao SS, et al. Childhood, adolescent, and adulthood adiposity are associated with risk of PCOS: a Mendelian randomization study with meta-analysis. Hum Reprod. 2023;38(6):1168–1182. doi: 10.1093/humrep/dead053.
   PubMed Web of Science ®Google Scholar
• Koivuaho E, Laru J, Ojaniemi M, et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes (Lond). 2019;43(7):1370–1379. doi: 10.1038/s41366-019-0318-z.
   PubMed Web of Science ®Google Scholar
• Kakoly NS, Khomami MB, Joham AE, et al. Ethnicity, obesity and the prevalence of impaired glucose tolerance and type 2 diabetes in PCOS: a systematic review and meta-regression. Hum Reprod Update. 2018;24(4):455–467. doi: 10.1093/humupd/dmy007.
   PubMed Web of Science ®Google Scholar
• Yu HF, Chen HS, Rao DP, et al. Association between polycystic ovary syndrome and the risk of pregnancy complications: a PRISMA-compliant systematic review and meta-analysis. Medicine (Baltimore). 2016;95(51):e4863. doi: 10.1097/MD.0000000000004863.
   PubMed Web of Science ®Google Scholar
• Wild RA, Rizzo M, Clifton S, et al. Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis. Fertil Steril. 2011;95(3):1073–1079.e11. doi: 10.1016/j.fertnstert.2010.12.027.
   PubMed Web of Science ®Google Scholar
• Tune JD, Goodwill AG, Sassoon DJ, et al. Cardiovascular consequences of metabolic syndrome. Transl Res. 2017;183:57–70. doi: 10.1016/j.trsl.2017.01.001.
   PubMed Web of Science ®Google Scholar
• Karoli R, Fatima J, Siddiqi Z, et al. Study of early atherosclerotic markers in women with polycystic ovary syndrome. Indian J Endocrinol Metab. 2012;16(6):1004–1008. doi: 10.4103/2230-8210.103021.
   PubMedGoogle Scholar
• Jabbour R, Ott J, Eppel W, et al. Carotid intima-media thickness in polycystic ovary syndrome and its association with hormone and lipid profiles. PLoS One. 2020;15(4):e0232299. doi: 10.1371/journal.pone.0232299.
   PubMed Web of Science ®Google Scholar
• Osibogun O, Ogunmoroti O, Kolade OB, et al. A systematic review and meta-analysis of the association between polycystic ovary syndrome and coronary artery calcification. J Womens Health (Larchmt). 2022;31(6):762–771. doi: 10.1089/jwh.2021.0608.
   PubMed Web of Science ®Google Scholar
• Sun D, Wu Y, Ding M, et al. Comprehensive meta-analysis of functional and structural markers of subclinical atherosclerosis in women with polycystic ovary syndrome. Angiology. 2022;73(7):622–634. doi: 10.1177/00033197211072598.
   PubMed Web of Science ®Google Scholar
• Wong ND, Budoff MJ, Ferdinand K, et al. Atherosclerotic cardiovascular disease risk assessment: an American Society for Preventive Cardiology clinical practice statement. Am J Prev Cardiol. 2022;10:100335. doi: 10.1016/j.ajpc.2022.100335.
   PubMedGoogle Scholar
• Boomsma CM, Eijkemans MJ, Hughes EG, et al. A meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome. Hum Reprod Update. 2006;12(6):673–683. doi: 10.1093/humupd/dml036.
   PubMed Web of Science ®Google Scholar
• Parikh NI, Gonzalez JM, Anderson CAM, et al. Adverse pregnancy outcomes and cardiovascular disease risk: unique opportunities for cardiovascular disease prevention in women: a scientific statement from the American Heart Association. Circulation. 2021;143(18):e902–e916. doi: 10.1161/CIR.0000000000000961.
   PubMed Web of Science ®Google Scholar
• Barnard L, Ferriday D, Guenther N, et al. Quality of life and psychological well being in polycystic ovary syndrome. Hum Reprod. 2007;22(8):2279–2286. doi: 10.1093/humrep/dem108.
   PubMed Web of Science ®Google Scholar
• Franik G, Krysta K, Madej P, et al. Sleep disturbances in women with polycystic ovary syndrome. Gynecol Endocrinol. 2016;32(12):1014–1017. doi: 10.1080/09513590.2016.1196177.
   PubMed Web of Science ®Google Scholar
• Prairie BA, Wisniewski SR, Luther J, et al. Symptoms of depressed mood, disturbed sleep, and sexual problems in midlife women: cross-sectional data from the Study of Women’s Health Across the Nation. J Womens Health (Larchmt). 2015;24(2):119–126. doi: 10.1089/jwh.2014.4798.
   PubMed Web of Science ®Google Scholar
• Zhang J, Ye J, Tao X, et al. Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: systematic review and meta-analysis. Front Endocrinol (Lausanne). 2022;13:971604. doi: 10.3389/fendo.2022.971604.
   PubMed Web of Science ®Google Scholar
• Baune BT, Stuart M, Gilmour A, et al. The relationship between subtypes of depression and cardiovascular disease: a systematic review of biological models. Transl Psychiatry. 2012;2(3):e92–e92. doi: 10.1038/tp.2012.18.
   PubMed Web of Science ®Google Scholar
• Wild RA, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab. 2010;95(5):2038–2049. doi: 10.1210/jc.2009-2724.
   PubMed Web of Science ®Google Scholar
• Dhesi AS, Murtough KL, Lim JK, et al. Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists. Am J Obstet Gynecol. 2016;215(5):579 e1-579–e5. doi: 10.1016/j.ajog.2016.07.043.
   Web of Science ®Google Scholar
• Elder P, Sharma G, Gulati M, et al. Identification of female-specific risk enhancers throughout the lifespan of women to improve cardiovascular disease prevention. Am J Prev Cardiol. 2020;2:100028. doi: 10.1016/j.ajpc.2020.100028.
   PubMedGoogle Scholar
• Teede HTC, Lave J, Dokra A, et al. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2023. 2023. Available from: https://www.monash.edu/__data/assets/pdf_file/0003/3379521/Evidence-Based-Guidelines-2023.pdf.
   Google Scholar
• Vogel B, Acevedo M, Appelman Y, et al. The Lancet women and cardiovascular disease commission: reducing the global burden by 2030. Lancet. 2021;397(10292):2385–2438. doi: 10.1016/S0140-6736(21)00684-X.
   PubMed Web of Science ®Google Scholar